image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

4Imprint - Shares hit new high of £20

February 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FOUR
  • Price:
  • 1940p
4Imprint has announced that given most of its operations (97% revenue) are based in the USA it will receive a major boost from President Trump’s reduction in corporation taxes with initial projections suggesting its rate will drop from c. 30% in 2017 to “the low 20s” from 2018 onwards. Not only will this lead to significantly higher eps but it will also improve group’s free cash generation.It also notes that the US legislation needs more detailed analysis with more detailed guidance to be provided with results in early March. The next scheduled announcement is a trading update on 17th January.Broker Liberum has raised FY’18 eps forecasts a chunky 13% to 125.8 cents (93.2p) and by 14% to 134.1 cents (99.3p) for FY’19. Peel Hun ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author